United States Pompe Disease Drugs Market Research Report Forecast 2017 to 2022
Delivery of the Report will take 2-3 working days once order is placed.
The United States Pompe Disease Drugs Market Research Report Forecast 2017-2022 is a valuable source of insightful data for business strategists. It provides the Pompe Disease Drugs industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Pompe Disease Drugs market study provides comprehensive data which enhances the understanding, scope and application of this report.
This report provides comprehensive analysis of
Genzyme（A Sanofi Company)
BioMarin
Amicus
Audentes
EpiVax
Oxyrane
Sangamo
Valerion Therapeutics
company 9
United States Pompe Disease Drugs Market: Product Segment Analysis
Liver Drugs
Heart Drugs
Muscle Drugs
United States Pompe Disease Drugs Market: Application Segment Analysis
Hospital
Clinic
Other
Reasons for Buying this Report
The United States Pompe Disease Drugs Market Research Report Forecast 2017-2022 is a valuable source of insightful data for business strategists. It provides the Pompe Disease Drugs industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Pompe Disease Drugs market study provides comprehensive data which enhances the understanding, scope and application of this report.
This report provides comprehensive analysis of
- Key market segments and sub-segments
- Evolving market trends and dynamics
- Changing supply and demand scenarios
- Quantifying market opportunities through market sizing and market forecasting
- Tracking current trends/opportunities/challenges
- Competitive insights
- Opportunity mapping in terms of technological breakthroughs
Genzyme（A Sanofi Company)
BioMarin
Amicus
Audentes
EpiVax
Oxyrane
Sangamo
Valerion Therapeutics
company 9
United States Pompe Disease Drugs Market: Product Segment Analysis
Liver Drugs
Heart Drugs
Muscle Drugs
United States Pompe Disease Drugs Market: Application Segment Analysis
Hospital
Clinic
Other
Reasons for Buying this Report
- This report provides pin-point analysis for changing competitive dynamics
- It provides a forward looking perspective on different factors driving or restraining market growth
- It provides a six-year forecast assessed on the basis of how the market is predicted to grow
- It helps in understanding the key product segments and their future
- It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
- It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
CHAPTER 1 POMPE DISEASE DRUGS MARKET OVERVIEW
1.1 Product Overview and Scope of Pompe Disease Drugs
1.2 Pompe Disease Drugs Market Segmentation by Type
1.2.1 United States Production Market Share of Pompe Disease Drugs by Type in 2016
1.2.1 Liver Drugs
1.2.2 Heart Drugs
1.2.3 Muscle Drugs
1.3 Pompe Disease Drugs Market Segmentation by Application
1.3.1 Pompe Disease Drugs Consumption Market Share by Application in 2016
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Pompe Disease Drugs (2011-2021)
CHAPTER 2 UNITED STATES ECONOMIC IMPACT ON POMPE DISEASE DRUGS INDUSTRY
2.1 United States Macroeconomic Analysis
2.2 United States Macroeconomic Environment Development Trend
CHAPTER 3 UNITED STATES POMPE DISEASE DRUGS MARKET COMPETITION BY MANUFACTURERS
3.1 United States Pompe Disease Drugs Production and Share by Manufacturers (2015 and 2016)
3.2 United States Pompe Disease Drugs Revenue and Share by Manufacturers (2015 and 2016)
3.3 United States Pompe Disease Drugs Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Pompe Disease Drugs Manufacturing Base Distribution, Production Area and Product Type
3.5 Pompe Disease Drugs Market Competitive Situation and Trends
3.5.1 Pompe Disease Drugs Market Concentration Rate
3.5.2 Pompe Disease Drugs Market Share of Top 3 and Top 5 Manufacturers
3.5.3 Mergers & Acquisitions, Expansion
CHAPTER 4 UNITED STATES POMPE DISEASE DRUGS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE
4.1 United States Pompe Disease Drugs Production and Market Share by Type (2012-2017)
4.2 United States Pompe Disease Drugs Revenue and Market Share by Type (2012-2017)
4.3 United States Pompe Disease Drugs Price by Type (2012-2017)
4.4 United States Pompe Disease Drugs Production Growth by Type (2012-2017)
CHAPTER 5 UNITED STATES POMPE DISEASE DRUGS MARKET ANALYSIS BY APPLICATION
5.1 United States Pompe Disease Drugs Consumption and Market Share by Application (2012-2017)
5.2 United States Pompe Disease Drugs Consumption Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
5.3.1 Potential Applications
5.3.2 Emerging Markets/Countries
CHAPTER 6 UNITED STATES POMPE DISEASE DRUGS MANUFACTURERS ANALYSIS
6.1 Genzyme（A Sanofi Company)
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Product Type, Application and Specification
6.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Business Overview
6.2 BioMarin
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Product Type, Application and Specification
6.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Business Overview
6.3 Amicus
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Product Type, Application and Specification
6.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Business Overview
6.4 Audentes
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Product Type, Application and Specification
6.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Business Overview
6.5 EpiVax
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Product Type, Application and Specification
6.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Business Overview
6.6 Oxyrane
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Product Type, Application and Specification
6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Business Overview
6.7 Sangamo
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Product Type, Application and Specification
6.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Business Overview
6.8 Valerion Therapeutics
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Product Type, Application and Specification
6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Business Overview
6.9 company
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Product Type, Application and Specification
6.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Business Overview
CHAPTER 7 POMPE DISEASE DRUGS MANUFACTURING COST ANALYSIS
7.1 Pompe Disease Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Pompe Disease Drugs
CHAPTER 8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
8.1 Pompe Disease Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Pompe Disease Drugs Major Manufacturers in 2016
8.4 Downstream Buyers
CHAPTER 9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
CHAPTER 10 MARKET EFFECT FACTORS ANALYSIS
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
CHAPTER 11 UNITED STATES POMPE DISEASE DRUGS MARKET FORECAST (2017-2022)
11.1 United States Pompe Disease Drugs Production, Revenue Forecast (2017-2022)
11.2 United States Pompe Disease Drugs Production, Consumption Forecast by Regions (2017-2022)
11.3 United States Pompe Disease Drugs Production Forecast by Type (2017-2022)
11.4 United States Pompe Disease Drugs Consumption Forecast by Application (2017-2022)
11.5 Pompe Disease Drugs Price Forecast (2017-2022)
CHAPTER 12 APPENDIX
1.1 Product Overview and Scope of Pompe Disease Drugs
1.2 Pompe Disease Drugs Market Segmentation by Type
1.2.1 United States Production Market Share of Pompe Disease Drugs by Type in 2016
1.2.1 Liver Drugs
1.2.2 Heart Drugs
1.2.3 Muscle Drugs
1.3 Pompe Disease Drugs Market Segmentation by Application
1.3.1 Pompe Disease Drugs Consumption Market Share by Application in 2016
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Pompe Disease Drugs (2011-2021)
CHAPTER 2 UNITED STATES ECONOMIC IMPACT ON POMPE DISEASE DRUGS INDUSTRY
2.1 United States Macroeconomic Analysis
2.2 United States Macroeconomic Environment Development Trend
CHAPTER 3 UNITED STATES POMPE DISEASE DRUGS MARKET COMPETITION BY MANUFACTURERS
3.1 United States Pompe Disease Drugs Production and Share by Manufacturers (2015 and 2016)
3.2 United States Pompe Disease Drugs Revenue and Share by Manufacturers (2015 and 2016)
3.3 United States Pompe Disease Drugs Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Pompe Disease Drugs Manufacturing Base Distribution, Production Area and Product Type
3.5 Pompe Disease Drugs Market Competitive Situation and Trends
3.5.1 Pompe Disease Drugs Market Concentration Rate
3.5.2 Pompe Disease Drugs Market Share of Top 3 and Top 5 Manufacturers
3.5.3 Mergers & Acquisitions, Expansion
CHAPTER 4 UNITED STATES POMPE DISEASE DRUGS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE
4.1 United States Pompe Disease Drugs Production and Market Share by Type (2012-2017)
4.2 United States Pompe Disease Drugs Revenue and Market Share by Type (2012-2017)
4.3 United States Pompe Disease Drugs Price by Type (2012-2017)
4.4 United States Pompe Disease Drugs Production Growth by Type (2012-2017)
CHAPTER 5 UNITED STATES POMPE DISEASE DRUGS MARKET ANALYSIS BY APPLICATION
5.1 United States Pompe Disease Drugs Consumption and Market Share by Application (2012-2017)
5.2 United States Pompe Disease Drugs Consumption Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
5.3.1 Potential Applications
5.3.2 Emerging Markets/Countries
CHAPTER 6 UNITED STATES POMPE DISEASE DRUGS MANUFACTURERS ANALYSIS
6.1 Genzyme（A Sanofi Company)
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Product Type, Application and Specification
6.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Business Overview
6.2 BioMarin
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Product Type, Application and Specification
6.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Business Overview
6.3 Amicus
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Product Type, Application and Specification
6.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Business Overview
6.4 Audentes
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Product Type, Application and Specification
6.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Business Overview
6.5 EpiVax
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Product Type, Application and Specification
6.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Business Overview
6.6 Oxyrane
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Product Type, Application and Specification
6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Business Overview
6.7 Sangamo
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Product Type, Application and Specification
6.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Business Overview
6.8 Valerion Therapeutics
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Product Type, Application and Specification
6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Business Overview
6.9 company
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Product Type, Application and Specification
6.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Business Overview
CHAPTER 7 POMPE DISEASE DRUGS MANUFACTURING COST ANALYSIS
7.1 Pompe Disease Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Pompe Disease Drugs
CHAPTER 8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
8.1 Pompe Disease Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Pompe Disease Drugs Major Manufacturers in 2016
8.4 Downstream Buyers
CHAPTER 9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
CHAPTER 10 MARKET EFFECT FACTORS ANALYSIS
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
CHAPTER 11 UNITED STATES POMPE DISEASE DRUGS MARKET FORECAST (2017-2022)
11.1 United States Pompe Disease Drugs Production, Revenue Forecast (2017-2022)
11.2 United States Pompe Disease Drugs Production, Consumption Forecast by Regions (2017-2022)
11.3 United States Pompe Disease Drugs Production Forecast by Type (2017-2022)
11.4 United States Pompe Disease Drugs Consumption Forecast by Application (2017-2022)
11.5 Pompe Disease Drugs Price Forecast (2017-2022)
CHAPTER 12 APPENDIX
LIST OF TABLES
Figure Picture of Pompe Disease Drugs
Table Classification of Pompe Disease Drugs
Figure United States Sales Market Share of Pompe Disease Drugs by Type in 2016
Table Application of Pompe Disease Drugs
Figure United States Sales Market Share of Pompe Disease Drugs by Application in 2016
Figure United States Pompe Disease Drugs Sales and Growth Rate (2011-2021)
Figure United States Pompe Disease Drugs Revenue and Growth Rate (2011-2021)
Table United States Pompe Disease Drugs Sales of Key Manufacturers (2015 and 2016)
Table United States Pompe Disease Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Pompe Disease Drugs Sales Share by Manufacturers
Figure 2016 Pompe Disease Drugs Sales Share by Manufacturers
Table United States Pompe Disease Drugs Revenue by Manufacturers (2015 and 2016)
Table United States Pompe Disease Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Pompe Disease Drugs Revenue Share by Manufacturers
Table 2016 United States Pompe Disease Drugs Revenue Share by Manufacturers
Table United States Market Pompe Disease Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Pompe Disease Drugs Average Price of Key Manufacturers in 2015
Figure Pompe Disease Drugs Market Share of Top 3 Manufacturers
Figure Pompe Disease Drugs Market Share of Top 5 Manufacturers
Table United States Pompe Disease Drugs Sales by Type (2012-2017)
Table United States Pompe Disease Drugs Sales Share by Type (2012-2017)
Figure United States Pompe Disease Drugs Sales Market Share by Type in 2015
Table United States Pompe Disease Drugs Revenue and Market Share by Type (2012-2017)
Table United States Pompe Disease Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Pompe Disease Drugs by Type (2012-2017)
Table United States Pompe Disease Drugs Price by Type (2012-2017)
Figure United States Pompe Disease Drugs Sales Growth Rate by Type (2012-2017)
Table United States Pompe Disease Drugs Sales by Application (2012-2017)
Table United States Pompe Disease Drugs Sales Market Share by Application (2012-2017)
Figure United States Pompe Disease Drugs Sales Market Share by Application in 2016
Table United States Pompe Disease Drugs Sales Growth Rate by Application (2012-2017)
Figure United States Pompe Disease Drugs Sales Growth Rate by Application (2012-2017)
Table Genzyme（A Sanofi Company) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Genzyme（A Sanofi Company) Pompe Disease Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Genzyme（A Sanofi Company) Pompe Disease Drugs Market Share (2012-2017)
Table BioMarin Basic Information, Manufacturing Base, Production Area and Its Competitors
Table BioMarin Pompe Disease Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table BioMarin Pompe Disease Drugs Market Share (2012-2017)
Table Amicus Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Amicus Pompe Disease Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Amicus Pompe Disease Drugs Market Share (2012-2017)
Table Audentes Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Audentes Pompe Disease Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Audentes Pompe Disease Drugs Market Share (2012-2017)
Table EpiVax Basic Information, Manufacturing Base, Production Area and Its Competitors
Table EpiVax Pompe Disease Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table EpiVax Pompe Disease Drugs Market Share (2012-2017)
Table Oxyrane Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Oxyrane Pompe Disease Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Oxyrane Pompe Disease Drugs Market Share (2012-2017)
Table Sangamo Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Sangamo Pompe Disease Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Sangamo Pompe Disease Drugs Market Share (2012-2017)
Table Valerion Therapeutics Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Valerion Therapeutics Pompe Disease Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Valerion Therapeutics Pompe Disease Drugs Market Share (2012-2017)
Table company 9 Basic Information, Manufacturing Base, Production Area and Its Competitors
Table company 9 Pompe Disease Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table company 9 Pompe Disease Drugs Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Pompe Disease Drugs
Figure Manufacturing Process Analysis of Pompe Disease Drugs
Figure Pompe Disease Drugs Industrial Chain Analysis
Table Raw Materials Sources of Pompe Disease Drugs Major Manufacturers in 2016
Table Major Buyers of Pompe Disease Drugs
Table Distributors/Traders List
Figure United States Pompe Disease Drugs Production and Growth Rate Forecast (2017-2022)
Figure United States Pompe Disease Drugs Revenue and Growth Rate Forecast (2017-2022)
Table United States Pompe Disease Drugs Production Forecast by Type (2017-2022)
Table United States Pompe Disease Drugs Consumption Forecast by Application (2017-2022)
COMPANIES MENTIONED
Genzyme（A Sanofi Company)
BioMarin
Amicus
Audentes
EpiVax
Oxyrane
Sangamo
Valerion Therapeutics
Figure Picture of Pompe Disease Drugs
Table Classification of Pompe Disease Drugs
Figure United States Sales Market Share of Pompe Disease Drugs by Type in 2016
Table Application of Pompe Disease Drugs
Figure United States Sales Market Share of Pompe Disease Drugs by Application in 2016
Figure United States Pompe Disease Drugs Sales and Growth Rate (2011-2021)
Figure United States Pompe Disease Drugs Revenue and Growth Rate (2011-2021)
Table United States Pompe Disease Drugs Sales of Key Manufacturers (2015 and 2016)
Table United States Pompe Disease Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Pompe Disease Drugs Sales Share by Manufacturers
Figure 2016 Pompe Disease Drugs Sales Share by Manufacturers
Table United States Pompe Disease Drugs Revenue by Manufacturers (2015 and 2016)
Table United States Pompe Disease Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Pompe Disease Drugs Revenue Share by Manufacturers
Table 2016 United States Pompe Disease Drugs Revenue Share by Manufacturers
Table United States Market Pompe Disease Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Pompe Disease Drugs Average Price of Key Manufacturers in 2015
Figure Pompe Disease Drugs Market Share of Top 3 Manufacturers
Figure Pompe Disease Drugs Market Share of Top 5 Manufacturers
Table United States Pompe Disease Drugs Sales by Type (2012-2017)
Table United States Pompe Disease Drugs Sales Share by Type (2012-2017)
Figure United States Pompe Disease Drugs Sales Market Share by Type in 2015
Table United States Pompe Disease Drugs Revenue and Market Share by Type (2012-2017)
Table United States Pompe Disease Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Pompe Disease Drugs by Type (2012-2017)
Table United States Pompe Disease Drugs Price by Type (2012-2017)
Figure United States Pompe Disease Drugs Sales Growth Rate by Type (2012-2017)
Table United States Pompe Disease Drugs Sales by Application (2012-2017)
Table United States Pompe Disease Drugs Sales Market Share by Application (2012-2017)
Figure United States Pompe Disease Drugs Sales Market Share by Application in 2016
Table United States Pompe Disease Drugs Sales Growth Rate by Application (2012-2017)
Figure United States Pompe Disease Drugs Sales Growth Rate by Application (2012-2017)
Table Genzyme（A Sanofi Company) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Genzyme（A Sanofi Company) Pompe Disease Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Genzyme（A Sanofi Company) Pompe Disease Drugs Market Share (2012-2017)
Table BioMarin Basic Information, Manufacturing Base, Production Area and Its Competitors
Table BioMarin Pompe Disease Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table BioMarin Pompe Disease Drugs Market Share (2012-2017)
Table Amicus Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Amicus Pompe Disease Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Amicus Pompe Disease Drugs Market Share (2012-2017)
Table Audentes Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Audentes Pompe Disease Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Audentes Pompe Disease Drugs Market Share (2012-2017)
Table EpiVax Basic Information, Manufacturing Base, Production Area and Its Competitors
Table EpiVax Pompe Disease Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table EpiVax Pompe Disease Drugs Market Share (2012-2017)
Table Oxyrane Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Oxyrane Pompe Disease Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Oxyrane Pompe Disease Drugs Market Share (2012-2017)
Table Sangamo Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Sangamo Pompe Disease Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Sangamo Pompe Disease Drugs Market Share (2012-2017)
Table Valerion Therapeutics Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Valerion Therapeutics Pompe Disease Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Valerion Therapeutics Pompe Disease Drugs Market Share (2012-2017)
Table company 9 Basic Information, Manufacturing Base, Production Area and Its Competitors
Table company 9 Pompe Disease Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table company 9 Pompe Disease Drugs Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Pompe Disease Drugs
Figure Manufacturing Process Analysis of Pompe Disease Drugs
Figure Pompe Disease Drugs Industrial Chain Analysis
Table Raw Materials Sources of Pompe Disease Drugs Major Manufacturers in 2016
Table Major Buyers of Pompe Disease Drugs
Table Distributors/Traders List
Figure United States Pompe Disease Drugs Production and Growth Rate Forecast (2017-2022)
Figure United States Pompe Disease Drugs Revenue and Growth Rate Forecast (2017-2022)
Table United States Pompe Disease Drugs Production Forecast by Type (2017-2022)
Table United States Pompe Disease Drugs Consumption Forecast by Application (2017-2022)
COMPANIES MENTIONED
Genzyme（A Sanofi Company)
BioMarin
Amicus
Audentes
EpiVax
Oxyrane
Sangamo
Valerion Therapeutics
